Sign In
4 Sep 2014 13:50
ļ»æ
Ā
Biofrontera AG
Ā ("Biofrontera" or the "Company")
Ā
Director Dealing
Ā
Biofrontera AG (AIM:B8F), the European biopharmaceutical company, announces that on 4 September 2014 Thomas Schaffer, the Chief Financial Officer of the Company, purchased 2,000 ordinary shares of no par value in the capital of the Company ("Ordinary Shares") at a price of EUR 2.320 per Ordinary Share. Subsequent to this transaction Mr Schaffer has a beneficial interest in 10,088 Ordinary Shares representing 0.045% of the issued ordinary share capital of the Company.
Ā
For further information, please contact:
Ā
Biofrontera AG Ā | Ā | ||
Prof. Hermann LĆ¼bbert, Chief Executive Officer Thomas Schaffer , Chief Financial Officer | Tel: + 49 (0) 214 - 87632 - 22 Ā | ||
Ā | Ā | ||
finnCap (Nomad and Broker) | Ā | ||
Geoff Nash / Christopher Raggett (Corporate Finance) | Tel: 020 7220 0500 | ||
Steven Norcross(Corporate Broking) | Ā | ||
Ā | Ā | ||
Investor Relations | Ā | ||
Seton Services | Ā | ||
Toni Vallen | Tel: 020 7603 6797 | ||
Ā | Ā | ||
Financial PR Gable Communications | Ā | ||
John Bick | Tel: 020 7193 7463 |
Ā
Ā
Ā
Ā
Follow the stocks
